Articles dans des revues avec comité de lecture (118)
  1. 4. Jacquemin, V., Antoine, M., Dom, G., Detours, V., Maenhaut, C., & Dumont, J. E. (2022). Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications. Cancers (Basel), 14(2). doi:10.3390/cancers14020280
  2. 5. Tarabichi, M., Demetter, P., Ruscas-Craciun, L. I., Maenhaut, C., & Detours, V. (2021). Thyroid cancer under the scope of emerging technologies. Molecular and cellular endocrinology, 541, 111491. doi:10.1016/j.mce.2021.111491
  3. 6. Augenlicht, A., Saiselet, M., Decaussin-Petrucci, M., Andry, G., Dumont, J. E., & Maenhaut, C. (2021). MiR-7-5p inhibits thyroid cell proliferation by targeting the EGFR/MAPK and IRS2/PI3K signaling pathways. Oncotarget, 12(16), 1587-1599. doi:10.18632/ONCOTARGET.28030
  4. 7. Dom, G., Dmitriev, P., Lambot, M.-A., Van Vliet, G., Glinoer, D., Libert, F., Lefort, A., Dumont, J. E., & Maenhaut, C. (2021). Transcriptomic signature of human embryonic thyroid reveals transition from differentiation to functional maturation. Frontiers in Cell and Developmental Biology, 9.
  5. 8. Saiselet, M., Rodrigues Vitória, J., Tourneur, A., Ruscas-Craciun, L. I., Spinette, A., Larsimont, D., Andry, G., Lundeberg, J., Maenhaut, C., & Detours, V. (2020). Transcriptional output, cell types densities and normalization in spatial transcriptomics. Journal of Molecular Cell Biology. doi:10.1093/jmcb/mjaa028
  6. 9. Kyrilli, A., Gacquer, D., Detours, V., Lefort, A., Libert, F., Twyffels, L., Van Den Eeckhaute, L., Strickaert, A., Maenhaut, C., De Deken, X., Dumont, J. E., Miot, F., & Corvilain, B. (2020). Dissecting the role of thyrotropin in the DNA damage response in human thyrocytes after 131I, γ radiation and H2O2. The Journal of clinical endocrinology and metabolism, 105(3), dgz185, 839-853. doi:10.1210/clinem/dgz185
  7. 10. Grieco, G., Wang, T., Delcorte, O., Spourquet, C., Janssens, V., Strickaert, A., Gaide Chevronnay, H. H., Liao, X. H., Bilanges, B., Refetoff, S., Vanhaesebroeck, B., Maenhaut, C., Courtoy, P. J., & Pierreux, C. (2020). Class III PI3K Vps34 Controls Thyroid Hormone Production by Regulating Thyroglobulin Iodination, Lysosomal Proteolysis, and Tissue Homeostasis. Thyroid, 30(1), 133-146. doi:10.1089/thy.2019.0182
  8. 11. Strickaert, A., Corbet, C., Spinette, S.-A., Ruscas-Craciun, L. I., Dom, G., Andry, G., Larsimont, D., Wattiez, R., Dumont, J. E., Feron, O., & Maenhaut, C. (2019). Reprogramming of Energy Metabolism: Increased Expression and Roles of Pyruvate Carboxylase in Papillary Thyroid Cancer. Thyroid, 29(6), 845-857. doi:10.1089/thy.2018.0435
  9. 12. Tarabichi, M., Antoniou, A., Le Pennec, S., Gacquer, D., De Saint Aubain, N., Ruscas-Craciun, L. I., Cielen, T., Laios, I., Larsimont, D., Andry, G., Dumont, J., Maenhaut, C., & Detours, V. (2018). Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers. The Journal of clinical endocrinology and metabolism. doi:10.1210/jc.2017-02279
  10. 13. Dom, G., Frank, S., Floor, S., Kehagias, P., Libert, F., Hoang, C., Andry, G., Spinette, A., Ruscas-Craciun, L. I., de Saint Aubin, N., Tresallet, C., Tissier, F., Savagner, F., Majjaj, S., Gutierrez-Roelens, I., Marbaix, E., Dumont, J. E., & Maenhaut, C. (2018). Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution. Oncotarget, 9(12), 10343-10359. doi:10.18632/oncotarget.23130
  11. 14. Strickaert, A., Saiselet, M., Dom, G., De Deken, X., Dumont, J. E., Feron, O., Sonveaux, P., & Maenhaut, C. (2017). Cancer heterogeneity is not compatible with one unique cancer cell metabolic map. Oncogene, 36(19), 2637-2642. doi:10.1038/onc.2016.411
  12. 15. Saiselet, M., Pita, J. M., Augenlicht, A., Dom, G., Tarabichi, M., Fimereli, D., Dumont, J. E., Detours, V., & Maenhaut, C. (2016). miRNA expression and function in thyroid carcinomas: A comparative and critical analysis and a model for other cancers. Oncotarget, 7(32), 52475-52492. doi:10.18632/oncotarget.9655
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Suivant >>